Correction: Crossject présentera au Biotech Showcase le 9 janvier à 16 h30 (Horaire de San Francisco)
09 janv. 2024 13h58 HE
|
CROSSJECT
Communiqué de presse Crossject présentera au Biotech Showcase le 9 janvier à 16 h30 (Horaire de San Francisco) Dijon, France 09 janvier, 2024 -- Crossject (ISIN : FR0011716265 ; Euronext : ALCJ),...
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
05 janv. 2024 09h30 HE
|
OKYO Pharma LTD
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
Axial Therapeutics to Present at Upcoming Conferences
05 janv. 2024 08h05 HE
|
Axial Therapeutics
WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024
02 janv. 2024 09h15 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Healis Therapeutics selected to speak on opening day of 2024 Biotech Showcase in San Francisco
05 déc. 2023 08h00 HE
|
Healis Therapeutics
Healis Co-Founders Sebastian De Beurs and Dr. Eric Finzi will be presenting on the company's neurotherapeutics pipeline and clinical development.
Axiom Real-Time Metrics Attending J.P. Morgan Healthcare and Biotech Showcase Conferences
08 janv. 2023 22h06 HE
|
Axiom Real-Time Metrics Inc
TORONTO, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.
04 janv. 2023 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), Dr. David Young, Processa Pharmaceuticals, CEO will present an update on Processa’s future therapeutic...
Cyclacel Pharmaceuticals to Present at Biotech Showcase and Participate in a Corporate Access Event During the J.P. Morgan Healthcare Conference in January 2023
15 déc. 2022 09h15 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
invIOs to present at Biotech Showcase
14 déc. 2022 08h00 HE
|
invIOs GmbH
VIENNA, Austria, Dec. 14, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces that CEO Peter...
Prolocor to Participate at Biotech Showcase 2022
10 janv. 2022 09h00 HE
|
Prolocor Inc
PHILADELPHIA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prolocor Inc, a healthcare startup developing an innovative precision diagnostic test that quantifies FcγRIIa on the surface of platelets, today...